Citigroup Inc Forte Biosciences, Inc. Transaction History

Citigroup Inc

$169 Billion
Q3 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 10, 2022	SELL	$1.07 - $1.55 $538 - $779	-503 Reduced 81.66%	113 $0
Q1 2022 May 12, 2022	SELL	$1.21 - $2.24 $2,314 - $4,285	-1,913 Reduced 75.64%	616 $1,000
Q4 2021 Feb 10, 2022	BUY	$2.02 - $3.36 $2,415 - $4,018	1,196 Added 89.72%	2,529 $5,000
Q3 2021 Nov 10, 2021	BUY	$2.96 - $36.67 $3,945 - $48,881	1,333 New	1,333 $4,000

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.